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Abstract
Background: Malaria still remains the leading cause of childhood morbidity and mortality in Uganda. Interventions
like malaria vaccines which reduce the malaria burden are needed in malaria endemic communities. There is need
to establish baseline characteristics in vaccine trial study sites. This study determined the following baseline
malariometric indices: spleen rates, bed net use, malaria parasitaemia and malaria episodes in an inception cohort
of children aged 12 – 60 months in Iganga district, Uganda.
Methods: In a longitudinal cohort study, 748 children were enrolled with 397 in an active follow up arm and 351
in a passive arm. The children in the two arms were followed for 6 months to determine the incidence of malaria
episodes.
Results: The overall baseline spleen rate was 8.2% (61/748) among the study participants. Of the households
surveyed, about 36% reported using bed nets and almost 30% of the users had insecticide-treated nets. 274 (36.6%)
of the study participants had a history of fever in the past 24 hrs at the time of the baseline survey. All participants
had a peripheral blood smear for malaria parasites done at enrollment with 76.8% having the asexual form of
malaria parasites. The malaria episodes per child per year were 1.5 and 0.79 in the active and passive follow up
arms respectively.
Conclusions: There is a high prevalence of malaria asexual parasitaemia in children below five years. The bed net
usage still remains low among this population. These baseline malariometric indices have important implication for
malaria control interventions.
Keywords: Malaria episodes, Parasitaemia, Surveillance, Iganga, Uganda
Background
Malaria still remains one of the leading global health
problems with more than half a million death per year
in Africa, occurring in children below 5 years of age [1].
Malaria control in resource limited settings has been
hindered mainly by increasing resistance to commonly
used anti-malarial drugs and under utilization of pre-
ventive measures [2]. The remedy for Africa remains in
drug development (artemisinin-based combination treat-
ments), preventive interventions (long-lasting, insecticide-
treated bed nets), improved diagnosis (rapid diagnostic
tests), community mobilization and development of effect-
ive vaccines [3-5]. However, understanding of the epidemi-
ology of malaria in malaria clinical trial sites is needed to
evaluate the impact of control interventions. The burden
of malaria can be studied using longitudinal studies which
employ the extended active follow-up methods to guide a
comprehensive evaluation of malaria infection outcomes
and incidence [2]. Well-defined cohorts from the sub –
Saharan Africa have been instrumental in characterizing
the epidemiology of malaria, exploring the acquisition of
immunity, and demonstrating the effectiveness of control
interventions such as insecticide-treated bed nets, inter-
mittent preventative treatments and vaccines [6-11]. * Correspondence: wbuwembo@yahoo.com
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received a grant from the European and Developing
Countries Clinical Trials Partnership (EDCTP), to strengthen
capacity in selected African Research institutions in con-
ducting malaria vaccine trials. Makerere University,
College of Health Sciences, Uganda, was one of the bene-
ficiaries of the sub-grants awarded by AMANET, but
baseline malariometric indices for site characterization to
aid in recruitment and follow up of the volunteers were
not available. The objective of the current study was to de-
scribe the baseline malariometric indices including spleen
rate, bed net use, in Iganga district, Uganda. Results from
this study were used together with other data [12] to pro-
vide guidance in conducting as well as setting up a cohort
for GMZ2 [13] vaccine trial.
Methods
Description of study site
Our study area in Iganga district comprised of six vil-
lages located in the neighborhood of Iganga district hos-
pital. Iganga district is predominantly rural with one
government hospital, 10 smaller governmental health fa-
cilities, three non-government facilities, 122 drug shops
and clinics. Iganga hospital is located about 120 kilome-
ters east of Kampala, the capital city of Uganda. The
total population of Mayuge/Iganga is about 70,000 with
the under five population being 11,000. Like elsewhere
in Uganda, malaria is one of the leading health problems.
The climate in Iganga is equatorial, with Plasmodium fal-
ciparum (P. falciparum) as the predominant malaria spe-
cies. Malaria transmission occurs throughout the year but
peaks are seen following maximal vector breeding after
the rains: periods April to June and September to December.
The annual entomologic inoculation rate (EIR) is not known,
but is reported to be >500 infective bites/person/year in
the neighboring district of Tororo [14].
The study site is a typical rural area, primarily residen-
tial, characterized by a high population density with low-
income single or two-roomed housing units. The local
economy is predominantly dependent on petty commer-
cial activities and small-scale farming. The principal mos-
quito vector is Anopheles gambiae sensu strictu and their
analysis for resistance markers is still ongoing.
Recruitment and demographic survey
A representative cohort of 748 children aged 1–5 years
participated in a six month longitudinal study to determine
the malaria episodes, the normal reference hematological
and biochemical ranges which have been reported else-
where [12] and also provide recruitment for a malaria vac-
cine study. The sample size of 300 per arm was estimated
based on assumptions of malaria incidence of 15% in the
active arm, with 95% confidence interval, and ability to de-
tect a vaccine efficacy of 30%. However, assuming a 15%
loss to follow up and non response for recruitment into
the vaccine study, 350 children were estimated for each
arm. The participant recruitment provided a cohort of
children for subsequent enrolment into a vaccine trial.
Prior to the start of the study, investigators met with ad-
ministrative government representatives to inform them
of the study, its objectives and explain the methodology.
Priority villages were selected and earmarked in consult-
ation with the district officials as these were noted to have
a large burden of malaria related problems. Through local
village meetings, residents from each village were in-
formed about the intended project objectives. Community
consent was sought before household screening for poten-
tial participants and subsequently individual consent was
obtained from each participant. Using a systematic ran-
dom sampling method, the initial household located in
the centre of each village was selected as a starting point
and every third household was approached for potential
enrolment and screening based on the eligibility criteria. If
the sampled household did not have an eligible participant
then the next household was approached. A resident of
the village was defined as a person anticipated to be stay-
ing primarily within that location for the next 6 months.
Over a two month period, teams of four study personnel
systematically covered the entire area of the six villages on
foot to identify and enumerate all households with help of
the local council official of that village. A household was
defined as any single permanent or semi-permanent struc-
ture acting as the primary residence for a person or group
of people. The enrolled households were assigned sequen-
tial unique numbers, written on a visible label fixed above
the doorway, and residents were given a household identi-
fication card. After enumeration, study personnel asked
the household head or guardian from each household
for verbal consent to participate in a brief demographic
survey. Using a standardized questionnaire, demographics
and malaria indicator information was collected. If no
adult resident was available, that household was excluded
from the survey.
Recruitment of the cohort
Household level recruitment was for one eligible child
from each household. If a household had more than one
eligible child then a raffle was conducted to enroll only
one child. From January 2010 to February 2010, experi-
enced home visitors approached households to systemat-
ically recruit from the previously generated list. Using
handheld GPS receivers they recorded households’ coor-
dinates and a brief description of the study was provided
in the appropriate language to parents and/or guardians.
Screening and enrollment
Interested potential participants were screened sequen-
tially until the desired sample size was achieved. Initial
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criteria of; 1) age one to five years; 2) agreement to come
to study clinic for any febrile episode or illness; 3) agree-
ment to avoid medications administered outside the
study; 4) agreement to remain in study area during the
six months follow up; 5) absence of known chronic disease
and 6) written informed consent provided by parent or
guardian. Children who passed initial screening were
assigned study numbers and underwent a history and
physical examination including temperature, height weight
measurement and abdominal examination. Severely mal-
nourished children [15], were excluded. Hemoglobin con-
centration was measured and those with hemoglobin
levels less than 9 g/dl were referred to the district hospital
for further management. Presence of bed net was verified
by direct observation at home. All children had a screen-
ing RDT performed and a thick blood smear performed
which was read later. Children having a history of fever in
the past 24 hours, a tympanic temperature of 38°C or
higher and a positive thick blood smear at the time of initial
screening were treated with Artemether – Lumefantrine
(according to their weight for 3 days) according to the
Uganda national treatment guidelines. A clinical examin-
ation was performed to assess the presence and size of
the spleen. Follow-up started when children fulfilled
all of our selection criteria and were free of symptomatic
malaria. The villages were divided by convenience into ac-
tive (nearby villages) and passive (further) villages.
Passive case detection
Children in the passive arm were visited every month by
trained field workers to document absences from the
study site and find out how they had been in the past
four weeks. Parents/guardians were encouraged to bring
their child to the malaria clinic if the child was unwell.
Active case detection
Children in the active follow up arm were visited twice
a week by field workers. A standardized questionnaire
was administered for collecting information regarding
illnesses that had occurred since the last visit, use of
health care facilities and medications used. At each
v i s i t ,t h et y m p a n i ct e m p e r a t u r ew a sr e c o r d e du s i n ga
digital thermometer. When fever (tympanic temperature
of ≥38°C) or history of recent fever (within the last
24 hours) was observed or reported for any study child, a
rapid diagnostic test (RDT, OPTIMAL®) and microscopy
of a stained blood smear were used to screen for malaria
and to confirm the presence of malaria parasites respect-
ively. Children found with any peripheral asexual malaria
parasitaemia in their blood were treated at the study
clinic accordingly following the Uganda national treat-
ment guidelines.
Microscopy
Thick blood smears were stained with 2% Giemsa for
30 minutes. Parasite density was estimated by counting
the number of asexual parasites per 500 white-blood cells
and calculating parasites per μL, using the actual white
blood cell count of the subject. A smear was judged to be
negative if no parasites were seen after examination of 100
high-powered fields. A second microscopist, who was un-
aware of the results of the first reading, re-read all slides.
A third reviewer resolved discordant results. The presence
of sexual forms of the parasites was also determined dur-
ing slide readings.
Data management and analysis
Baseline data were collected in the field on written forms,
verified, checked by investigators and entered into the Open
Clinica (https://www.openclinica.com) database. Double
entry verification from paper questionnaires was performed
to assure accuracy. Categorical variables were compared
using the chi-square test and continuous variables using a
two-sample t-test. A p-value <0.05 (two-tailed) was con-
sidered statistically significant. Analysis was done using
SPSS version 10.0 (SPSS, Chicago, IL, USA).
Ethical issues
Written informed consent was obtained from the parent/
guardian(s) of children for their participation in the cohort
study. The study was approved by Makerere University
School of Medicine, Research and Ethics Committee
2009/172 and by the Ugandan National Council of Sci-
ence and Technology (records no. HS 765).
Results
A total of 1161 households were screened, of which 748
were enrolled, 374 (32.2%) households had no children
aged less than 5 years, while 39 (3.4%) declined to con-
sent for the study.
Table 1: shows the demographics characteristics of
study cohort (n = 748). The mean age was 2.3± 1.2 years.
Majority of the respondents were from the Basoga tribe
which is the predominant tribe in Iganga district. The
overall spleen rate at baseline was 8.2% (61/748) among
the study participants. There was no significant difference
between participants in the active and passive arms in
age, sex and temperature. However the spleen rate was
significantly different between these two arms (P=0.002).
Use of bed nets
Among the study population, the overall bed net usage
among the two arms was reported at 36.4% (273/748) of
whom 82.8% (226/273) reported that they were using in-
secticide treated nets. Overall, 64% (475/748) of the study
participants reported that they did not own bed nets or
had not used one during the preceding night before the
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ence in bed net usage or ownership between the active
and passive follow up groups (P = 0.777).
Malaria
Among the study participants 274 (36.6%) reported his-
tory of fever in the past 24 hours before the baseline sur-
vey was conducted. Overall 61% (457/748) of the study
subjects had a positive screening RDT test at enrolment.
Fifty eight percent (265/457) of those with a positive
RDT were from the active arm. However, out of the 274
subjects with history of fever in the preceding 24 hours,
only 66.4% (182/274) had a positive screening RDT
malaria test at enrolment. And, the thick blood smears
showed that 76.8% (575/748) of the study participants
had asexual P. falciparum malaria parasites in their per-
ipheral blood smears at baseline screening during recruit-
ment (Table 1). Nearly, 99% (569/575) of these subjects had
a mono-infection of P. falciparum while 1% (6/575) had a
dual infection with both P. falciparum and P. vivax.W h i l e
the median asexual parasite density (Figure 1A and C) was
4224 Parasitized erythrocytes (PE)/uL (IQR : 1,005-14,040)
and the children with asexual parasite density greater than
5000 PE/uL comprised 35.5%. The gametocyte carriage rate
was 30.4% with median gametocytemia of 40 gametocytes/
uL (IQR: 20 –100; Figure 1B). Over 90% of children with
gametocytes, carried less than 400 gametocytes per uL of
blood (Figure 1D).
Table 1 Demographic characteristics of study participants
Characteristics Arm
Active Passive Chi-square p-value
(N=397) % (N=351) %
Age in years
Less than 1 127 32.0 107 30.5
2-3 193 48.6 180 51.3
4-5 77 19.4 64 18.2
Sex
Male 221 55.6 191 54.4
Female 176 44.3.4 160 45.6
Ethnicity
Basoga 392 98.7 341 97.2
Others 5 1.3 10 2.8
Slept in bed net
Yes 143 36.0 130 37.1 0.08 0.777
No 254 64.0 221 62.9
Was the bed net treated
Yes 109 76.8 117 90.0 9.07 0.002*
No 34 23.8 13 10.0
Fever in the past 24 hours
Yes 153 43.6 121 34.5 1.330 0.248
No 244 56.4 230 65.5
Spleen rate
Yes 21 5.3 40 11.4 9.211 0.002*
No 376 94.7 311 88.6
RDT results
Positive 265 66.8 192 54.7 10.483 0.001*
Negative 132 33.2 159 45.3
Malaria asexual parasitemia
Positive 294 70.1 281 80.1 5.057 0.025
Negative 103 29.9 70 19.9
*Statistically Significant.
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Total malaria cases for the 6 months follow-up period
(March – August 2010) were 892 among the study par-
ticipants (Table 2). Of these 603 (67.6%) were among the
active arm, while 289 (32.4%) occurred in the passive
arm group. The peaks for the most malaria cases seen at
the malaria clinic were in the months of May for the ac-
tive arm and April for the passive arm. The weekly clinic
attendances were higher for the active arm as compared
to the passive arm during the follow up period except dur-
ing week 2 (Figures 2 and 3). The malaria episodes that
occurred during the follow up period were 1.5 and 0.79
per child per year for active and passive arms respectively.
Children aged 2–3 years in both arms had a higher mal-
aria incidence compared to the other age groups (Table 3).
Of the 748 study participants, 311 (40.9%) had no malaria
episode during the study period, 200 (26.3%) had an epi-
sode, 124 (16.3%) had two episodes, 71(9.3%) had three
episodes, 28 (3.7%) had four episodes, 14 (1.8%) had five
episodes, 7 (0.9%) had six episodes, 2 (0.3%) had eight epi-
sodes. One child (0.1%) had seven episodes of malaria; an-
other had nine episodes while a third had 16 episodes
during the follow up period.
Discussion
Longitudinal studies in well-defined cohorts are critical
to improving our understanding of the malaria incidence
and associated factors before interventions can be intro-
duced. In the current study, a representative cohort of
children from a rural setting where malaria is highly en-
demic was enrolled.
The overall prevalence of malaria parasitaemia at base-
line in the study population was 76.8%, this suggests that
Iganga is a holoendemic area. This corroborates the gen-
eral observation that the under fives are more vulnerable
to the disease in areas of high transmission [16]. How-
ever it is higher than the reported malaria prevalence of
56% in Eastern Uganda [17] probably due to the differ-
ence in timing of the surveys. Our survey was conducted
during one of the high transmission periods of March to
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Figure 1 Endemicity of malaria at the malaria vaccine site of Iganga. To determine the endemicity of malaria at the malaria vaccine site
of Iganga, 748 children aged 1 to 5 years were screened for history or presence of fever and confirmed by microscopy of stained blood
smear. Majority (76.8%) of the children had P. falciparum in the blood. Except one child, all children had <180,000 PE/uL (see A, C). The
median gametocytemia was 40 /uL (IQR: 20–100; see B&D ).
Table 2 Total malaria cases for the 6 months follow-up
period (March – August 2010) according to the study arm
Month Active (n = 397) Passive (n = 351) Total
No % No %
March 115 81.0 27 19.0 142
April 113 61.4 71 38.6 184
May 152 67.9 72 32.1 224
June 128 71.5 51 28.5 179
July 53 57.0 40 43.0 93
August 42 60.0 28 40.0 70
Total 603 67.6 289 32.4 892
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acquired immunity builds up in older children following
repeated exposure to the parasite and is manifested by
lower parasite densities and fewer clinical malarial epi-
sodes than in younger children and less exposed under
fives [18]. In our study children aged 2–3 years had a
higher incidence in both groups. This may be due to the
increased exposure due to the waning maternal antimal-
arial antibodies, this corroborates earlier reports which
showed children aged 2 – 4 years to have an increased
risk of cerebral malaria [19].
However, the prevalence of those with symptoms of
fever was 36.6% at the baseline survey. This further
highlights the fact that some children may have asymp-
tomatic malaria. P. falciparum was the predominant spe-
cies of malaria parasite identified in this study; with
majority 99% of the children having a Plasmodium fal-
ciparum mono-infection. The high prevalence of malaria
and P. falciparum mono infection noted in this study is
an indication of a worsening malaria situation around
the study area which might be indicative of poor access
or adherence to effective control measures such as the
Figure 2 Monthly malaria incidences for the six month follow up period. The malaria incidences were plotted against months for the six
months the study was carried out. The active arm had a higher incidence throughout the six months and the highest peaks were in May and
April in the active and passive arms respectively.
Figure 3 Weekly malaria incidences for the 6 months follow-up period. The incidences were plotted against weeks for the months the
study was carried out. The active arm had a higher incidence on a weekly basis for most of the months with an overlap during the last one and
half months.
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to earlier findings reported from other study sites
within the region [20]. Only 36.4% of the study chil-
dren reported using bed-nets of whom only 30% were
using insecticide-treated nets. This is lower than the
reported 33% of ITN usage in Eastern Uganda [17]. This
study population is predominantly poor and rural and
this might affect the probability of owning a bed net
as well.
The overall spleen rate in this study is 8.2%. This sup-
ports the fact that children aged less than five years have
a more pronounced immunological response (including
splenic enlargement) to malaria [21]. However, other
hematological diseases and factors responsible for spleen
rate were not assessed in this study. The higher spleen
rate in the passive arm was probably due to the persist-
ent parasitemias as the children were only brought to
the clinic for treatment when they fell ill. Persistent
parasitaemia from treatment failure is known to contrib-
ute to splenic enlargement, in earlier reports [22]. A
study in Nigeria has shown that the spleen rate may re-
duce as prompt access to effective treatment to malaria
improves [23].
The episodes of malaria in the active follow up arm
was twice that of the passive arm during the period of
observation. This corroborates other reports which have
used similar methodology for malariometric indices [24].
This might be due to weekly reminders of sending chil-
dren to the clinic whenever they felt unwell as compared
to those in the passive arm. Some of the malaria infec-
tions in the passive arm may have been treated and not
reported to the clinic. The proportion of children with
malaria reduced steadily with increasing episodes of
the infection. The susceptibility of some children to
more malaria episodes as the one who had up to six-
teen episodes compared to others is unexplained. This
may be due to differences in the host genetics which
were not part of this study but will need further stud-
ies to elucidate.
Conclusions
This study shows that malaria remains a major health
problem among children aged less than five residing in
Iganga district, eastern Uganda. The bed net usage still
remains low among this population. This baseline study
provides the important malariometric data required for
vaccine intervention studies to determine their efficacy
in our setting.
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